July 28, 2016 7:21 AM ET

Life Sciences Tools and Services

Company Overview of RainDance Technologies, Inc.

Company Overview

RainDance Technologies, Inc. develops, manufactures, and sells proprietary systems, consumables, and assays that enable ultra-sensitive detection and analysis of complex genetic diseases in tissue and liquid biopsies in life science and translational research settings. The company offers ThunderStorm system that generates one million unique droplet-based single molecule polymerase chain reaction reactions for approximately 20,000 targeted genetic loci, or specific regions of the genome; and provides sensitivity, accuracy, genomic coverage, and uniformity to commercial service laboratories. It also offers ThunderBolts system that provides predefined assays, or primers that target genetic regi...

749 Middlesex Turnpike

Billerica, MA 01821

United States

Founded in 2004

104 Employees

Phone:

978-495-3300

Fax:

978-528-6090

Key Executives for RainDance Technologies, Inc.

Chairman of the Board, Chief Executive Officer, Chairman of Science & Innovation Committee and Member of Compensation Committee
Age: 65
Co-Founder and Chief Technology Officer
Age: 47
Chief Financial Officer
Age: 62
Compensation as of Fiscal Year 2016.

RainDance Technologies, Inc. Key Developments

RainDance Technologies, Inc. Announces Executive Changes

RainDance Technologies, Inc. announced the appointment of Kathy Ordoñez as Chief Executive Officer. She continues in her current role as Chairman of the Board of Directors. Former CEO Roopom Banerjee has left the Company to pursue other opportunities. After joining the Board of RainDance in July 2014, Ms. Ordoñez established and led the Science and Innovation Committee for the Board and was named the Company's Chairman of the Board in September 2015. As Senior Vice President at Quest Diagnostics, she was initially responsible for leading the company’s R&D effort and later provided oversight to multiple businesses commercializing diagnostic products and testing services. She joined Quest Diagnostics as part of its acquisition of Celera Corporation in 2011. Ms. Ordoñez was previously the Chief Executive Officer at Celera and a founder of Celera Diagnostics. Earlier in her career, Ms. Ordoñez held several senior positions at Hoffmann La-Roche, overseeing the formation of Roche Molecular Systems, where she served as President and Chief Executive Officer, and led the wide-scale commercial application of the Polymerase Chain Reaction (PCR) technology to the research, diagnostic and forensic fields.

RainDance Technologies, Inc. and Blood Systems Research Institute Collaborate to Develop Ultra-Sensitive Assays to Detect and Quantify HIV Latency

RainDance Technologies, Inc. and Blood Systems Research Institute announced a research collaboration to develop blood-based assays and protocols for the precise measurement of the human immunodeficiency virus (HIV) latent reservoir using RainDance’s RainDrop Digital PCR and ThunderBolts Next-Generation Sequencing (NGS) Enrichment Systems. As part of this collaboration, BSRI will provide access to the RainDance products to key thought leaders at the new amfAR Institute for HIV Cure Research, an innovative collaborative enterprise focused on developing and validating new approaches that can ultimately lead to a functional cure for HIV. Built on RainDance’s unified picodroplet platform, the RainDrop and ThunderBolts Systems generate millions of individual droplet-based tests per sample, providing the dynamic range and quantitation essential for massively-parallel yet precise single molecule analysis. The collaboration between RainDance and BSRI aims to develop ultra-sensitive, highly precise and low cost NGS and digital PCR methods to detect, measure and monitor replication competent latent HIV with absolute quantitation from limited amounts of bio-available fluids.

RainDance Technologies, Inc. Appoints Kathy Ordonez as the Chairman of the Board of Directors

RainDance Technologies, Inc. announced the appointment of Kathy Ordoez as chairman of its board of directors. Ms. Ordoez brings more than 30 years of experience in the life sciences and diagnostics industries, and has served on the board of directors since 2014, and as the chair of the board’s science and innovation committee. As senior vice president at Quest Diagnostics, Kathy Ordoez was responsible for leading the company's businesses in diagnostic products, insurer services, clinical trials and healthcare information technology products and also led research and development. Ordoez was previously the chief executive officer at Celera and a founder of Celera Diagnostics.

Similar Private Companies By Industry

Company Name Region
10X Genomics, Inc. United States
4G Clinical, Inc. United States
AAPharmaSyn LLC United States
Abiant, Inc. United States
aBioBot, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact RainDance Technologies, Inc., please visit raindancetech.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.